The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
October 25th 2024
New research indicates semaglutide reduced albuminuria and body weight in CKD patients without diabetes, highlighting its potential renal benefits.
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Using Non-Insulin Drug Therapies in Type 1 Diabetes: Promising Future
October 21st 2015Type 1 diabetes mellitus (T1DM) is treated by necessity with insulin analogues in an attempt to mimic normal physiological insulin profiles. Regardless, this approach is rarely completely successful and most T1DM patients experience fluctuating or suboptimal glucose control, significant hypoglycemia and microvascular tissue complications.
Restoring the Ability to Say No: Programming Food Responses
October 21st 2015Most adults in developed nations struggle with their weight. Ample quantities of high-quality foods (and plenty of sugar- and fat-laden snacks) do more than just nourish us. They allow us to overindulge; in fact, they tend to make people eat mindlessly.
Managing Antithrombotic Risk in ACS Patients with History of GI Bleeding
October 20th 2015The title of the talk was Cardiogastroenterologist: Managing Antiplatelet and Antithrombotic Agents.1 and it was presented by Dr Neena Abraham, professor of medicine, department of gastroenterology and hepatology, Mayo Clinic, Scottsdale, Arizona.
Antiplatelet Timing before Cardiac Surgery
October 14th 2015Researchers continue to look at the age-old question of when to stop treatment with antiplatelet drugs if surgery is necessary. Stopping them too soon increases risk of clotting. Stopping them too late increases risk of excessive blood loss.
Arrhythmia: Substrate Ablation Has Benefits
Substrate-based ablation (in which all damaged areas of the lower heart muscle are treated) has advantages over ablation of clinical ventricular tachycardia (in which the origin of the abnormal rhythm is pinpointed, then the target tissue is scarred with electrical current). Researchers at Montefiore Einstein Center for Heart and Vascular Care report on a study.
Study results show patients with atrial fibrillation who stopped taking warfarin before surgery received no benefit from temporary "bridging" with low-molecular-weight heparin. Patients who received no anticoagulation while off warfarin did not experience significantly more thromboembolic events, but they did experience significantly lower fewer incidents of serious bleeding.
Study: "Obesity Paradox" in Cardiovascular Disease Does Not Exist
The "obesity paradox" suggests that patients with excess weight are associated with better survival among individuals with cardiovascular disease -a mysterious and confounding phenomenon that has been demonstrated in many clinical studies.
Study: Waterpipe Establishments Likely to Set up Shop Near College Campuses
Misconceptions about waterpipe smoke content may lead users to underestimate the health risks, which include all the cardiovascular risks of cigarette smoking, tobacco dependence, and even nicotine withdrawal.
Psoriasis Patients and Depression, What's the Connection?
A recently published article in JAMA Dermatology explored the curious relationship between psoriasis and depression, since psoriasis has been considered a risk factor for depression, and depression a trigger for psoriasis.
Hospital Uses Established Tools to Reduce Diabetes Medication Errors
September 29th 2015An article published in Clinical Interventions in Aging outlined a large hospital's successful quality improvement interventions over 5 years to reduce medication errors in their large population of diabetic patients.
Halted Heart Device Trial Leaves Ethics, Efficacy Questions
A device manufacturer's decision to halt a trial of a pump-and-filter system that removes excess salt and fluid from heart failure patients left researchers with promising but statistically insignificant data. It also raised questions about whether that manufacturer acted ethically.
Beta Blockers More Effective than Lower Heart Rate in Ambulatory Heart Failure Patients
As new drugs for lowering heart rate become available, physicians treat heart failure patients may chose these agents instead of increasing doses of beta blockers. A multi-center study finds that could be the wrong choice.
Drop That Big Mac and Check Out This One-Hour Timeline of Unhealthy Effects
September 24th 2015Devoted soda drinkers began to lose their minds when an infographic outlining the harmful effects a single can of Coca-Cola has on the body in one hour began circulating the Internet. Now a new infographic has revealed what a Big Mac from McDonald's can do to the body in the same amount of time.
Sex After Heart Attack Is Safe, Studies Show
Physicians often fail to counsel recovering heart attack patients on whether they are at risk of having another myocardial infarction triggered by sexual activity. In a letter to the Journal of the American College of Cardiology, Dietrich Rothenbacher, MD, MPH and colleagues have reassuring data.
Testosterone Therapy and CVD Risk: AACE Physicians Take a Stance
September 22nd 2015The link between testosterone therapy and cardiovascular risks has been a hot topic of debate, with researchers offering competing evidence and statements supporting or refuting the existence of link between testosterone supplementation and increased cardiovascular risk. Now, physicians from the American Association of Clinical Endocrinologists (AACE) have publicly stated their position on the issue.